ClearPoint Neuro (CLPT) Depreciation & Amortization (CF) (2011 - 2026)
ClearPoint Neuro (CLPT) reported Depreciation & Amortization (CF) of $86000.0 for Q1 2026, down 16.5% on a YoY basis from $103000.0 in Q1 2025, and down 65.46% sequentially from $249000.0 in Q4 2025.
ClearPoint Neuro (CLPT) Depreciation & Amortization (CF) (2011 - 2026) Analysis & Trends
ClearPoint Neuro (CLPT) has 15 years of Depreciation & Amortization (CF) data on file, last reported at $86000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 16.5% year-over-year to $86000.0; the trailing twelve-month figure through Mar 2026 stood at $797000.0 (down 5.12% YoY), and the FY2025 full-year result was $814000.0, down 16.94% from the prior year.
- Depreciation & Amortization (CF) eased to $86000.0 in Q1 2026, from $249000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $396000.0 in Q2 2025 to a low of $20000.0 in Q4 2022.
- A 5-year average of $161764.7 and a median of $156000.0 in 2023 frame the typical range for Depreciation & Amortization (CF).
- Across the five-year window, Depreciation & Amortization (CF) soared 815.0% in 2023 and slumped 75.0% in 2025, its largest moves.
- Tracing CLPT's Depreciation & Amortization (CF) over 5 years: stood at $20000.0 in 2022, then soared by 815.0% to $183000.0 in 2023, then surged by 31.15% to $240000.0 in 2024, then advanced by 3.75% to $249000.0 in 2025, then plunged by 65.46% to $86000.0 in 2026.
- Business Quant data shows CLPT's Depreciation & Amortization (CF) at $86000.0 in Q1 2026, $249000.0 in Q4 2025, and $66000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 67.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 310.25 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | ClearPoint Neuro | 434.51 Mn | 398.91 Mn | 7.76 Mn | 86,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 86,000.00 |
| Mar 31, 2026 | 86,000.00 |
| Dec 31, 2025 | 249,000.00 |
| Dec 31, 2025 | 249,000.00 |
| Sep 30, 2025 | 66,000.00 |
| Sep 30, 2025 | 66,000.00 |
| Jun 30, 2025 | 396,000.00 |
| Jun 30, 2025 | 396,000.00 |
| Mar 31, 2025 | 103,000.00 |
| Mar 31, 2025 | 103,000.00 |
| Dec 31, 2024 | 240,000.00 |
| Dec 31, 2024 | 240,000.00 |
| Sep 30, 2024 | 264,000.00 |
| Sep 30, 2024 | 264,000.00 |
| Jun 30, 2024 | 233,000.00 |
| Jun 30, 2024 | 233,000.00 |
| Mar 31, 2024 | 243,000.00 |
| Mar 31, 2024 | 243,000.00 |
| Dec 31, 2023 | 183,000.00 |
| Dec 31, 2023 | 183,000.00 |